ACTIV-3: Therapeutics for Inpatients With COVID-19

NCT04501978 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2753

Enrollment

NIH

Sponsor class

Conditions

Covid19

Interventions

BIOLOGICAL: LY3819253
DRUG: Placebo
BIOLOGICAL: Remdesivir
BIOLOGICAL: VIR-7831
BIOLOGICAL: BRII-196/BRII-198
BIOLOGICAL: AZD7442
DRUG: MP0420
DRUG: PF-07304814

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]